Page last updated: 2024-11-04

terfenadine and Glaucoma, Angle Closure

terfenadine has been researched along with Glaucoma, Angle Closure in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"Paclitaxel (PTX) is one of the most important breast cancer treatment drugs."7.76[Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma]. ( Eguchi, H; Kogure, Y; Komatsubara, K; Matsuhisa, T; Miyoshi, K, 2010)
"Paclitaxel (PTX) is one of the most important breast cancer treatment drugs."3.76[Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma]. ( Eguchi, H; Kogure, Y; Komatsubara, K; Matsuhisa, T; Miyoshi, K, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komatsubara, K1
Miyoshi, K1
Kogure, Y1
Matsuhisa, T1
Eguchi, H1

Other Studies

1 other study available for terfenadine and Glaucoma, Angle Closure

ArticleYear
[Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:1

    Topics: Anti-Allergic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Hypersensitivity; Fe

2010